Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...
Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...
The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
Welcome, everyone. I'm Dr. John Whyte, the chief medical officer at WebMD. Ankylosing spondylitis is a type of arthritis that causes pain and stiffness in your spine. It usually starts in your ...
Health on MSN7mon
Signs and Symptoms of ArthritisPsoriatic arthritis is a complex disease that causes widespread symptoms. Besides the changes to your joints and skin, PsA ...
It is approved for use in rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical ...
Discover how biologic therapies impact infection risks in ankylosing spondylitis (AS) patients. A KOBIO registry study ...
By Erica Patino March 18, 2024 What to Expect When You’re Starting an IL-6 Inhibitor to Treat Rheumatoid Arthritis What ... to JAK Inhibitors for Ankylosing Spondylitis JAK inhibitors are ...
The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback